The global “Conjunctivitis Treatment Market” is set to gain traction from the rising technological advancements in the field of ophthalmology. Besides, the increasing discovery of new techniques of drug delivery would also impact the market positively. This information is given by Fortune Business Insights™ in a recently published report, titled, “Conjunctivitis Treatment Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Antibiotics, Antiviral, Anti-allergic, Artificial Tear and Others), By Disease Type (Bacterial Conjunctivitis, Viral Conjunctivitis, and Allergic Conjunctivitis) By Route of Administration (Topical, Oral, and Intravitreal), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies & Drug Stores), and Regional Forecast, 2020-2027.” The report further states that the conjunctivitis treatment market size was USD 3.85 billion in 2019 and is projected to reach USD 4.38 billion by 2027, exhibiting a CAGR of 3.7% during the forecast period.

Major Conjunctivitis Treatment Market Key players covered in the report include:

  • Allergan
  • Akorn, Incorporated
  • Eyevance Conjunctivitis Treatment LLC.
  • NOVARTIS AG
  • Santen Pharmaceutical Co., Ltd
  • Alcon
  • Bausch & Lomb Incorporated
  • Others key market players

Get Request a Sample Copy of the Conjunctivitis Treatment Report:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/conjunctivitis-treatment-market-103488

Our research methodology is robust and includes data triangulation based on bottom-up and top-down approaches. We validated the approximate market number with the help of primary research. Secondary research was conducted to find out detailed information about mergers and acquisitions, collaborations, joint ventures, and agreements. At the same time, we have derived significant information about the market dynamics associated with growth drivers, trends, and obstacles.

It offers figurative estimations for upcoming years on the basis of the recent developments and historic data. For gathering information and estimating revenue for all segments, researchers have used top-down and bottom-up approaches. On the basis of data collected from primary and secondary research and trusted data sources the report will help both existing and new aspirants for market to figure out and study the market’s needs, market size, and competition.

Conjunctivitis Treatment Market Analysis 2021:

Drivers & Restraints-

Rising Awareness Programs about Eye-related Diseases will Propel Growth

Conjunctivitis can be of three types, namely, allergic, viral, and bacterial. The National Centre for Biotechnology Information mentioned that these types of diseases vary from person to person according to the season of the year and the patient’s age. It also spreads rapidly through direct contact, such as sneezing, coughing, and hands. Also, numerous companies are trying to launch new drug formulations and innovative drug delivery systems for faster recovery of the patients. Apart from that, ocular disorder management and the increasing awareness programs about eye-related diseases would contribute to the conjunctivitis treatment market growth in the coming years.

Competitive Landscape-

Key Players Focus on Receiving Fast Track Approvals for Their New Drugs

The companies operating in the market are presently focusing on investing hefty amounts of money to conduct research and develop activities. These are helping them to develop new drugs for conjunctivitis treatment. They are also trying to receive approvals for their novel drugs from the regulatory bodies. Below are two of the latest industry developments:

  • April 2020: Ocular Therapeutix™, Inc., a biopharmaceutical firm declared the Phase 3 clinical trial results. It was conducted to find out the efficacy and safety of DEXTENZA® for the treatment of ocular itching caused by allergic conjunctivitis. As per the results, DEXTENZA is capable of treating the disease.
  • May 2017: The U.S. Food and Drug Administration (FDA) announced its approval of a New Drug Application (NDA) named Zerviate. It will be used to treat ocular itching that is caused by allergic conjunctivitis. It is considered to be the first topical ocular formulation of Nicox, an ophthalmology company based in France.

COVID-19 to Contribute to a Lower Growth Due to Strong Decline in Hospital Visits

The outbreak of the COVID-19 pandemic across the globe is set to negatively impact the global market growth. Despite the patients suffering from conjunctivitis tend to be at a high risk of getting injected by viral conjunctiva that is usually caused because of adenovirus, the market is expected to undergo a decline. While coronavirus also causes several similar ocular signs and symptoms, such as conjunctivitis infection, watery discharge, photophobia, and eye irritation. Due to the stringent lockdowns imposed by governments across the globe, the postponement or cancellations of non-life-threatening medical visits is expected to restrict the market growth as lesser prescriptions for conjunctivitis will be issued in this time period.

Have Any Query? Ask Our Experts:

https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/conjunctivitis-treatment-market-103488

Table of Content:

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Key Industry Developments (Mergers, Acquisitions, and Partnerships, etc.)
    • Pipeline Analysis
    • New Product Launches, Key Market Players
    • Prevalence of Conjunctivitis, by key Countries/region
    • COVID-19 Impact on Global Conjunctivitis Treatment Market
  • Global Conjunctivitis Treatment Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Drug Class
      • Antibiotics
      • Antiviral
      • Anti-allergic
      • Artificial Tears
      • Others
    • Market Analysis, Insights and Forecast – By Disease Type
      • Bacterial Conjunctivitis
      • Viral Conjunctivitis
      • Allergic Conjunctivitis
    • Market Analysis, Insights and Forecast – By Route of Administration
      • Topical
      • Oral
    • Market Analysis, Insights and Forecast – By Distribution Channel
      • Hospital Pharmacies
      • Online Pharmacies
      • Retail Pharmacies & Drug Stores
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa
  • North America Conjunctivitis Treatment Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis – By Drug Class
      • Antibiotics
      • Antiviral
      • Anti-allergic
      • Artificial Tears
      • Others
    • Market Analysis – By Disease Type
      • Bacterial Conjunctivitis
      • Viral Conjunctivitis
      • Allergic Conjunctivitis
    • Market Analysis – By Route of Administration
      • Topical
      • Oral
    • Market Analysis – By Distribution Channel
      • Hospital Pharmacies
      • Online Pharmacies
      • Retail Pharmacies & Drug Stores
    • Market Analysis – By Country
      • U.S.
      • Canada
  • Europe Conjunctivitis Treatment Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis – By Drug Class
      • Antibiotics
      • Antiviral
      • Anti-allergic
      • Artificial Tears
      • Others
    • Market Analysis – By Disease Type
      • Bacterial Conjunctivitis
      • Viral Conjunctivitis
      • Allergic Conjunctivitis
    • Market Analysis – By Route of Administration
      • Topical
      • Oral
    • Market Analysis – By Distribution Channel
      • Hospital Pharmacies
      • Online Pharmacies
      • Retail Pharmacies & Drug Stores
    • Market Analysis – By Country/ sub-region
      • U.K.
      • Germany
      • France
      • Spain
      • Italy
      • Scandinavia
      • Rest of Europe
  • Asia Pacific Conjunctivitis Treatment Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis – By Drug Class
      • Antibiotics
      • Antiviral
      • Anti-allergic
      • Artificial Tears
      • Others
    • Market Analysis – By Disease Type
      • Bacterial Conjunctivitis
      • Viral Conjunctivitis
      • Allergic Conjunctivitis
    • Market Analysis – By Route of Administration
      • Topical
      • Oral
    • Market Analysis – By Distribution Channel
      • Hospital Pharmacies
      • Online Pharmacies
      • Retail Pharmacies & Drug Stores
    • Market Analysis – By Country/ sub-region
      • Japan
      • China
      • India
      • Australia
      • Southeast Asia
      • Rest of Asia Pacific

Toc Continue…

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune -411045, Maharashtra, India.

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

 

Related Reports :

Plastic Injection Molding For Medical Device Market

Plastic Injection Molding For Medical Device Market Size

Plastic Injection Molding For Medical Device Market Share

Plastic Injection Molding For Medical Device Market Trends

Plastic Injection Molding For Medical Device Market Growth

Recombinant Proteins Market Analysis

Recombinant Proteins Market Business Opportunities

Recombinant Proteins Market Key Players

Recombinant Proteins Market Demand

Recombinant Proteins Market Competitive Landscape

Leave a Reply

Your email address will not be published. Required fields are marked *